As of 4:00pm ET
| -0.0349 / -4.72%|
The 1 analysts offering 12-month price forecasts for Caladrius Biosciences Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +41.86% increase from the last price of 0.70.
The current consensus among 2 polled investment analysts is to Hold stock in Caladrius Biosciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.